🇺🇸 FDA
Patent

US 9249243

Antibacterial antisense oligonucleotide and method

granted A61KA61K48/00A61P

Quick answer

US patent 9249243 (Antibacterial antisense oligonucleotide and method) held by Sarepta Therapeutics, Inc. expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K48/00, A61P, A61P31/04